Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear factor of activated T-cells, cytoplasmic 3 (NFATc3) is a member of the NFAT family of transcription factors, encoded by the NFATC3 gene in humans. It is chiefly expressed in the thymus and immune cells (particularly T cells and macrophages), where it regulates inducible gene expression, most notably cytokines such as IL-2 and TNFα. NFATc3 is maintained as a phosphorylated cytoplasmic protein in resting cells; upon stimulation (typically via antigen receptor signaling), a calcium/calcineurin pathway triggers its dephosphorylation and nuclear import, enabling binding to DNA and transcriptional activation of immune/inflammatory genes. NFATc3 also influences differentiation and gene expression in non-lymphoid cell types (such as adipocytes and macrophages). Dysregulation of NFATc3 is implicated in cancer progression (as seen in PDAC), immune disorders, and inflammatory lung injury, making it a therapeutic target for immunosuppressive drugs and biomarker studies.
Inhibition of calcineurin phosphatase blocks dephosphorylation and nuclear import of NFAT family members, including NFATc3, thereby suppressing cytokine gene transcription and immune activation.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear factor of activated T-cells, cytoplasmic 3 (NFATc3).